Related to this topic: Leaflets | Support | Patient+ | UK Guidelines | Online Videos | News | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Secondary Prevention of Ischaemic Heart Disease
The recently revised Joint British Societies' guidelines on prevention of cardiovascular disease (CVD) in clinical practice recommend that cardiovascular disease prevention should focus equally on the following three groups of patients who are at high risk of cardiovascular disease:1
- People with established atherosclerotic CVD
- People with diabetes mellitus (type 1 or 2)
- Apparently healthy individuals at high risk (CVD risk of 20% or greater over 10 years) of developing symptomatic atherosclerotic disease.
There are separate articles that discuss Primary Prevention of Cardiovascular Disease, How to use the coronary risk prediction charts for primary prevention and Cardiac Rehabilitation.
- Consider setting up disease register and systematic recall with nurse-led secondary prevention clinic.2,3
- Smoking cessation: all patients should be actively discouraged from smoking. Repeated brief supportive advice combine with nicotine replacement therapy when needed.
- Keep total dietary intake of fat a maximum of 30% of total energy intake, with intake of saturated fats 10% or less of total fat intake and the intake of dietary cholesterol to less than 300 mg/day. Saturated fats should be replaced with an increased intake of monounsaturated fats.
- Consumption of fresh fruit and vegetables should be increased to at least 5 portions per day. A mediterranean diet has been shown to reduce mortality. Regular intake of fish and other sources of omega 3 fatty acids (at least two servings of fish per week).
- Limit the intake of salt to less than 100 mmol/l day (less than 6 g of sodium chloride or less than 2.4 g of sodium per day)
- Alcohol consumption should be limited to 3 units/day (21 units/week) for men and 2 units/day (14 units/week) for women.
- Patients should be encouraged to exercise regularly:
- Regular aerobic physical activity of at least 30 mins per day, most days of the week, should be taken (e.g. fast walking/swimming).
- Exercise training has been shown to slow the progression or partially reverse the severity of coronary atherosclerosis.
- Aerobic exercise can modify all the components of the metabolic syndrome with a decrease in blood pressure and triglycerides, increase in HDL, and an improvement of insulin sensitivity.
- Weight control:
- Overweight patients should be encouraged to lose weight through a combination of diet and exercise.
- Maintain ideal body weight for adults (body mass index 20-25 kg/m2) and avoid central obesity (waist circumference in white caucasians less than 102 cm (40 inches) in men and less than 88 cm (35 inches) in women; in Asians the recommended targets are less than 90 cm in men and less than 80 cm in women.1
The recently revised Joint British Societies' guidelines on prevention of cardiovascular disease have made the following recommendations for secondary prevention and for other high risk groups.1
Blood pressure
See separate article on Hypertension:
- The optimal blood pressure target is less than 140 mm Hg systolic and less than 85 mm Hg diastolic.
- In selected higher risk people, e.g. established atherosclerotic disease, diabetes, and chronic renal failure, a lower blood pressure target of less than 130 mm Hg and less than 80 mm Hg may be more appropriate.
- Beta-blockers:
- Recommended for all people following myocardial infarction unless there are contraindications.
- ACE inhibitors:
- Recommended for people with symptoms or signs of heart failure at the time of myocardial infarction, or those with persistent left ventricular systolic dysfunction (ejection fraction less than 40%) following infarction.
- Should be considered for others with coronary artery disease, especially if the blood pressure is not below the target of less than 130 mm Hg systolic and less than 80 mm Hg diastolic.
- An angiotensin II receptor blocker is an alternative to an ACE inhibitor if an ACE inhibitor is associated with side effects.
- An ACE inhibitor should be considered in combination with a thiazide diuretic in all people with an established stroke, especially if the blood pressure is not below the target of less than 130 mm Hg systolic and less than 80 mmHg diastolic.
- Calcium channel blockers and diuretics:
- Should be considered in all high risk people if the blood pressure is not below the target, though purely as secondary prevention agents CCBs are ineffective.
See separate article on Hyperlipidaemia:
- The optimal total cholesterol target is less than 4.0 mmol/l and LDL cholesterol less than 2.0 mmol/l, or a 25% reduction in total cholesterol and a 30% reduction in LDL cholesterol, whichever gets the person to the lowest absolute value.
- Fasting lipids should be estimated at least eight weeks after an acute cardiovascular event and, if necessary, the dose of statin up-titrated to achieve the total and LDL cholesterol targets. HDL cholesterol and fasting triglycerides should be measured and considered at the same time.
- Statins are recommended for:
- All high risk people with established atherosclerotic disease
- In the following people with diabetes:
- All those who are aged 40 years or more with either type 1 or 2 diabetes
- People aged 18-39 years with either type 1 or 2 diabetes and who have at least one of the following:
- Retinopathy (pre-proliferative, proliferative, maculopathy)
- Nephropathy, including persistent microalbuminuria
- Poor glycaemic control (HbA1c greater than 9%)
- Elevated blood pressure requiring antihypertensive therapy
- Raised total blood cholesterol (greater than 6.0 mmol/l)
- Features of metabolic syndrome (central obesity and fasting triglyceride greater than 1.7 mmol/l (non-fasting > 2.0 mmol/l) and/or HDL cholesterol less than 1.0 mmol/l in men or less than 1.2 mmol/l in women)
- Family history of premature CVD in a first degree relative.
- Primary prevention for those who are at high total risk of developing CVD if the total cholesterol and LDL cholesterol targets have not been achieved.
- Other classes of lipid lowering drugs (particularly fibrates, bile acid sequestrants, cholesterol absorption inhibitors, nicotinic acid, omega-3 (n-3) fatty acids) should be considered in addition to a statin if the total and LDL cholesterol targets have not been achieved, or if there are other lipid abnormalities, e.g. HDL cholesterol or triglycerides.
Blood glucose and diabetes
- In all high risk people the optimal fasting glucose is less than 6.0 mmol/l.
- For people with impaired fasting glycaemia or impaired glucose tolerance: review annually to reassess glucose regulation and all other cardiovascular risk factors.
- People with type 1 and 2 diabetes mellitus: rigorous control of glycaemia. The optimal target for glycaemic control in diabetes is a fasting or pre-prandial glucose value of 4.0-6.0 mmol/l and an HbA1c less than 6.5%.
Antithrombotic therapy
- Coronary or peripheral atherosclerosis
- Aspirin 75 mg daily is recommended for life for all people with coronary or peripheral atherosclerotic disease.
- If aspirin is contraindicated, or there are side effects, then clopidogrel is appropriate.
- Anticoagulation should be considered for selected people at risk of systemic embolisation from large myocardial infarctions, heart failure, left ventricular aneurysm, or paroxysmal tachyarrhythmias.
- Cerebral atherosclerotic disease (non-haemorrhagic)
- All people with a history of cerebral infarction, or transient ischaemic attack, and who are in sinus rhythm, should take low dose aspirin plus dipyridamole M/R for two years following the initial event to prevent stroke recurrence as well as other vascular events.
- For those who have a further ischaemic cerebrovascular event while taking aspirin and dipyridamole M/R, then changing aspirin for clopidogrel should be considered.
- Anticoagulation should be considered for all people with atrial fibrillation who are at moderate (aged 60-75 years without additional risk factors) to high risk (over 75 years, or over 60 years with other risk factors such as hypertension, diabetes, or left ventricular dysfunction) to reduce the risk of a further stroke.
- If oral anticoagulation is contraindicated, or cannot be tolerated, antiplatelet therapy should be considered instead.
- There is no evidence of benefit for anticoagulation in people with ischaemic stroke who are in sinus rhythm.
- Primary prevention of CVD in those at high risk:
- Aspirin 75 mg daily is recommended for all people over the age of 50 years who have a total CVD risk greater than 20%, and in selected people with diabetes (greater than 50 years, or who are younger but have had the disease for more than 10 years, or who are already receiving treatment for hypertension), once the blood pressure has been controlled to at least less than 150mm Hg systolic and less than 90 mm Hg diastolic.
Antiarrhythmic agents
- Amiodarone significantly reduces the risk of cardiac and all-cause mortality after MI and in those with high risk of arrhythmic death.
- Beta-blockers (see above) have a favourable interaction with amiodarone, with additional reduction in mortality (however sotalol increases mortality after MI in those with LV dysfunction).
Surgery
After assessment with exercise tolerance test, echocardiography, angiography, and scanning, the following may be beneficial where appropriate:
- Coronary artery bypass grafting: reduces mortality compared to medical treatment alone, particularly in those with poor left ventricular function.
- Percutaneous transluminal coronary angioplasty.
- Intracoronary stent: particularly useful for restenosis after PTCA.
- Atherectomy by various methods, and transmyocardial laser revascularisation are less common procedures used.
Document references
- No authors listed, JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart. 2005 Dec;91 Suppl 5:v1-52.
- Murchie P, Campbell NC, Ritchie LD, et al; Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care. BMJ. 2003 Jan 11;326(7380):84. [abstract]
- Moher M, Yudkin P, Wright L, et al; Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ. 2001 Jun 2;322(7298):1338. [abstract]
Internet and further reading
- SIGN Clinical Guideline; Risk estimation and the prevention of cardiovascular disease, February 2007.
- NICE Clinical Guidance; MI: secondary prevention (May 2007).
- Leon AS, Franklin BA, Costa F, et al; Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2005 Jan 25;111(3):369-76. [abstract]
DocID: 2762
Document Version: 20
DocRef: bgp24601
Last Updated: 28 Mar 2008
Review Date: 28 Mar 2010
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicineInformation leaflets related to this topic (^ top of page)
Aspirin to Prevent Blood Clots
Cholesterol
Cholesterol - A Summary
Healthy Eating
High Blood Pressure (Hypertension)
Myocardial Infarction - After the MI
Myocardial Infarction - Medication
Obesity and Overweight
Physical Activity For Health
Preventing Cardiovascular Diseases
Preventing Heart Disease - A Summary
Smoking - The Facts
Smoking - Tips on StoppingPatient Support related to this topic (^ top of page)
BHF National Centre for Physical Activity and Health
British Cardiac Patients Association
British Heart Foundation
Chest Heart & Stroke Scotland
Circulation Foundation
H.E.A.R.T. UK
National Heart Forum
Northern Ireland Chest, Heart & StrokeMedical reference articles in PatientPlus related to this topic (^ top of page)
Cardiac Rehabilitation
Cholesterol-lowering Sterols and Stanols
Coronary Revascularisation
Epidemiology of IHD
Murmurs And Heart Sounds In Children
Primary Prevention of Cardiovascular Disease (CVD)UK guidelines related to this topic (^ top of page)
Guidelines on Coronary Heart DiseaseOnline videos related to this topic (^ top of page)
Online videos on Coronary Heart DiseaseRecent news items related to this topic (^ top of page)
Doctors demand freeze on use of diabetes drug for heart patientsLinks to other selected websites related to this topic (^ top of page)
Coronary Artery DiseaseOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
Medical equipment products related to this topic (^ top of page)
Fitness Aids
Health Monitors - Blood Pressure
Books related to this topic (^ top of page)
Coronary Heart Disease (Understanding)
Coronary Heart Disease : British Medical Association's Family Doctor Series
Want to search some more? Use the Google Search box below to search our site.

Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
